Sponsor Dossier
Specialised Therapeutics Pharma
Sponsor Dossier for Specialised Therapeutics Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: APLIDIN
- Brand: SKYTROFA
- Brand: YONDELIS
- Brand: YORVIPATH
- Brand: ZEPZELCA
- Device (sponsor): Empty self-injector, electronic
About
Specialised Therapeutics Pharma is an Australian Private Company with ABN 77609261430, registered in Victoria. The entity is active and registered for GST.
Portfolio
Specialised Therapeutics Pharma has 5 brands on the ARTG, of which 5 are indexable. The portfolio includes 4 brands with Product Information on file, 3 brands with PBAC outcomes on record, and 5 brands with AusPARs on record. Notable brands include APLIDIN, SKYTROFA, YONDELIS, YORVIPATH, and ZEPZELCA.
Therapeutic focus —
Oncology: 3 brands — Endocrinology: 2 brands
PBS footprint
Specialised Therapeutics Pharma has 1 brand with at least one PBS-listed item. The latest PBS schedule date the portfolio touched was 2026-05-01.
Regulatory activity
The most recent PBAC outcome for Specialised Therapeutics Pharma was 2025-07-01, with 3 brands holding PBAC outcomes on record. The most recent AusPAR was 2025-05-20, with 5 brands holding AusPARs on record.